Association between hyperlipidemia and microalbuminuria in essential hypertension

Kidney International, Supplement

Volumn 56, Issue 71, 1999, Pages

  Campese, Vito M ^a   Bianchi, Stefano ^b   Bigazzi, Roberto ^b  

^a LAC USC MEDICAL CENTER   (United States)

^b NONE

Author keywords

Blood pressure; Cardiovascular risk; Hypertension; Microalbuminuria; Urinary albumin excretion

Indexed keywords

ALBUMINURIA; BLOOD PRESSURE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; URINE; ARTERY DIAMETER; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CREATININE CLEARANCE; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; INSULIN RESISTANCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MICROALBUMINURIA; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ALBUMINURIA; BLOOD PRESSURE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION;

ALBUMIN; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL; URIC ACID;

EID: 0032974323     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. MOGENSEN CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356-360, 1984
2. MESSENT JW, ELLIOT TG, HILL RG, JARRET RJ, KEEN H, VIBERTI GC Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: A twenty-three-year follow-up study. Kidney Int 41:836-839, 1992
3. BIGAZZI R, BIANCHI S, CAMPESE VM, BALDARI G: Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron 61:94-97, 1992
4. AGRAWAL B, BERGER A, WOLF K, LUFT FC: Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens 14:223-228, 1996
5. OPSAHL JA, ABRAHAM PA, HALSTENSON CE, KEANE WF: Correlation of office and ambulatory blood pressure measurements with urinary albumin and N-acetyl-beta-D-glucosaminidase excretions in essential hypertension. Am J Hypertens 1:S117-S120, 1988
6. PARVING HH, JENSEN HE, MOGENSEN CE, EVRIN PE: Increased urinary albumin excretion rate in benign essential hypertension. Lancet i:1190-1192, 1974
7. CERASOLA G, COTTONE S, MULE G, NARDI E, MANGANO MT, ANDRONICO G, CONTORNO A, LI VECCHI M, GAGLIONE P, RENDA F, PIAZZA G, VOLPE V, LISI A, FERRARA L, PANEPINTO N, RICCOBENE R: Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension. J Hypertens 14:915-920, 1996
8. BIANCHI S, BIGAZZI R, BALDARI G, SGHERRI GP, CAMPESE VM: Diurnal variation of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 7:23-29, 1994
9. BIGAZZI R, BIANCHI S, NENCI R, BALDARI D, BALDARI G, CAMPESE VM: Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. J Hum Hypertens 9:827-833, 1995
10. HAFFNER SM, STERN MP, GRUBER KK, HAZUDA HP, MITCHELL BD, PATTERSON JK:. Microalbuminuria. A marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 10:727-731, 1990
11. NOSADINI R, CIPOLLINA MR, SOLINI A, SAMBATARO M, MOROCUTTI A, DORIA A, FIORETTO P, BROCCO E, MUOLLO B, FRIGATO F: Close relationship between microalbuminuria and insulin resistance in essential hypertension and non-insulin dependent diabetes mellitus. J Am Soc Nephrol 3(Suppl):S56-S63, 1992
12. KAPELRUD H, BANGSTAD HJ, DAHL-JORGENSEN K, BERG K, HANSSEN KF: Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria. Brit Med J 303:675-678, 1991
13. KEANE WF: Lipids and the kidney. Kidney Int 46:910-920, 1994
14. TOLINS JP, STONE BG, RAIJ L: Interactions of hypercholesterolemia and hypertension in initiation of glomerular injury. Kidney Int 41:1254-1261, 1992
15. KEANE WF, MULCAHY WS, KASISKE BL, KIM Y, O'DONNELL MP: Hyperlipidemia and progressive renal disease. Kidney Int 39 (Suppl 31):S41-S48, 1991
16. TONOLO G, CICCARESE M, BRIZZI P, PUDDU L, SECCHI G, CALVIA P, ATZENI MM, MELIS MG, MAIOLI M: Reduction of albumin excretion rate in normotensive microalbuminuric type 2 diabetic patients during long-term simvastatin treatment. Diabetes Care 20:1891-1895, 1997
17. KLAHR S, SCHREINER G, ICHIKAWA I: The progression of renal disease. N Engl J Med 318:1657-1666, 1988
18. FERRANNINI E, BUZZIGOLI G, BONADONNA R, GIORICO MA, OLEGGINI M, GRAZIADEI L, PEDRINELLI R, BRANDI L, BEVILACQUA S: Insulin resistence in essential hypertension. N Eng J Med 317:350-357, 1987
19. BIANCHI S, BIGAZZI R, VALTRIANI C, CHIAPPONI I, SGHERRI G, BALDARI G, NATALI A, FERRANNINI E, CAMPESE VM: Elevated serum insulin levels in patients with essential hypertension and microalbuminuria. Hypertension 23:681-687, 1994
20. BIANCHI S, BIGAZZI R, QUINONES GALVAN A, MUSCELLI E, BALDARI G, PECORI N, CIOCIARO D, FERRANINI E, NATALI A: Insulin resistance in microalbuminuric hypertension: Sites and mechanism. Hypertension 26:789-795, 1995
21. DORIA A, FlORETTO P, AVOGARO A, CARRARO A, MOROCUTTI A, TREVISAN R, FRIGATO F, CREPALDI G, VIBERTI GC, NOSADINI R: Insulin resistance is associated with high sodium-lithium countertransport in essential hypertension. Am J Physiol 261:684-691, 1991
22. FERRARI P, WEIDMANN P, SHAW S, GIACHINO D, RIESEN W, ALLEMAN Y, HEYNEN G: Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med 91:589-596, 1991
23. CRUZ AB, AMATUZIO DS, GRANDE F, HAY LJ: Effect of intraarterial insulin on tissue cholesterol and fatty acids in alloxan diabetic dogs. Circ Res 9:39-43, 1961
24. CAPRON L, JARNET J, KAZANDJIAN S, HOUSSET E: Growth promoting effects of diabetes and insulin on arteries. Diabetes 35:973-978, 1988
25. KRONE W, GRETEN H: Evidence for post-transcriptional regulation by insulin of 3 Hydroxy-3-methylgIutaryl coenzyme A reductase and sterol synthesis in human mononuclear leucocytes. Diabetologia 26:366-369, 1984
26. DEFRONZO RA, COOKE CR, ANDRES R, FALOONA GR, DAVID PJ: The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 55:845-855, 1975
27. BIGAZZI R, BIANCHI S, BALDARI D, SGHERRI G, BALDARI G, CAMPESE VM: Microalbuminuria in salt-sensitive patients: A marker for renal and cardiovascular risk factors. Hypertension 23:195-199, 1994
28. PEDRINELLI R, BELLO VD, CATAPANO G, TALARICO L, MATERAZZI F, SANTORO G, GIUSTI C, MOSCA F, MELILLO E, FERRARI M: Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinemia in non diabetic atherosclerotic patients. Arteriosclerosis Thrombosis 13:900-906, 1993
29. AGEWALL S, PERSSON B, SAMUELSSON O, LJUNGMAN S, HERLITZ H, FAGEBERG B: Microalbuminuria in treated hypertensive men at high risk of coronary disease. The Risk Factor Intervention Study Group. J Hypertens 11:461-469, 1993
30. YUDKIN JS, FORREST RD, JACKSON CA: Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet ii:530-533, 1988
31. BIGAZZI R, BIANCHI S, BALDARI G, CAMPESE VM: Microalbuminuria predicts cardiovascular and renal insufficiency in patients with hypertension. J Hypertens 16:1325-1333, 1998
32. SCHMIEDER RE, VEELKEN R, GATZKA CD, RUDDEL H, SCHACHINGER H: Predictors for hypertensive nephropathy: Results of a 6-year follow-up study in essential hypertension. J Hypertens 13:357-365, 1994
33. RUILOPE LM, CAMPO C, RODRIGUEZ-ARTALEJO F, LAHERA V, GARCIA ROBLES R, RODICIO JL: Blood pressure and renal function: Therapeutic implications. J Hypertens 14:1259-1263, 1996